← Back to Clinical Trials
Recruiting NCT06850961

NCT06850961 A Digital Health Intervention to Promote Self-management in Patients With Chronic Obstructive Pulmonary Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06850961
Status Recruiting
Phase
Sponsor Western Norway University of Applied Sciences
Condition Chronic Obstructive Pulmonary Disease (COPD)
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-01-06
Primary Completion 2027-12-31

Trial Parameters

Condition Chronic Obstructive Pulmonary Disease (COPD)
Sponsor Western Norway University of Applied Sciences
Study Type INTERVENTIONAL
Phase N/A
Enrollment 90
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2025-01-06
Completion 2027-12-31
Interventions
Digital health intervention by using a mobile applicationFeasibilty study and qualitative interview studies

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Dyspnea, cough, and chronic mucus hypersecretion are common symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD), which increases risk of infections followed by exacerbations, often leading to hospitalization, disease progression and mortality. This patient group requires lifelong treatment in healthcare. A mobile application was developed to facilitate adherence to evidence-based guidelines for tailored breathing and airway clearance techniques to enhance self-management. The app is only in Norwegian and has a Norwegian name which is "Pust Deg Bedre" (PDB). The PDB app is fully developed and tested and can be downloaded for free. The app seems promising as a treatment tool, but has not yet been clinical evaluated. This project aims to 1) explore the feasibility of providing the app for patients with COPD, 2) explore the patients' with COPD experiences with the use of the PDB-app in treating dyspnea and mucus secretion, 3) explore the physiotherapists' experiences with the use of the PDB-app in treating dyspnea and mucus secretion, 4) explore the physiotherapists' experiences with implementing the PDB-app in treatment of patients with COPD, 5) explore the patients' experiences with the education in use of the PDB-app, and 6) At a 6-month follow up: explore the physiotherapists experiences with the usefulness and applicability of PBD-app, and to generally explore their experiences with participating in the project.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of Chronic Obstructive Pulmonary Disease * Mucus-related issues ≥3 times per week * Speak and write Norwegian * Ability to independently operate a smartphone and/or iPad Exclusion Criteria: * Severe mental illness * Substance abuse that hinder participation in the study

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology